AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis

RecruitingPhase 2, Phase 3Ages 18 Years - 36 YearsFemaleHopital Foch
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Women suffering from endometriosis and/or adenomyosis may also suffer from infertility. GnRH agonist injection could improve implantation and therefore increase the pregnancy rate in these patients. This study was designed to evaluate effects of the additional of GnRH agonist (single or 2 doses) to the routine oestrogens and progestins use as support before Frozen Embryon Transfer as compared to oestrogens and progestins only.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Women aged 18 to 36 years (women โ‰ฅ18 years to \<36 years) with endometriosis and / or adenomyosis * Having benefited from In vitro fertilisation /intracytoplasmic micro-injection with freeze all and for whom the frozen embryon transfer of a blastocyst is planned * A normal uterine cavity * An MRI showing endometriosis and / or adenomyosis during the inclusion visit * Having signed a consent form * Being affiliated to a Health Insurance Plan. Exclusion Criteria: * Patient aged \<18 years and โ‰ฅ 36 years * BMI\> 35 * History of implantation failures (โ‰ฅ 2) * Endometrial alterations: synechiae, polyps, myomas, hyperplasia, hematometra * known hydrosalpinx uni or bilateral * MRI showing no endometriosis or adenomyosis * Hypersensitivity to GnRH, GnRH analogues, or any of the excipients of Decapeptyl 3 mg * Known hypersensitivity to estradiol * Known hypersensitivity to progesterone * Known hypersensitivity to acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs * Known hypersensitivity to folic acid * Known hypersensitivity to cefixime or an antibiotic in the cephalosporin group * Known hypersensitivity to levofloxacin or any other quinolone * History of tendinopathies related to the administration of fluoroquinolones * Epilepsy * Hypersensitivity to contrast agents for MRI * Known or suspected breast cancer or history of breast cancer * Known or suspected genital tract cancer or history of genital cancer * known or suspected estrogen-dependent malignant neoplasms * Undiagnosed genital haemorrhage * Untreated endometrial hyperplasia * History of idiopathic venous thrombo-embolic accident or evolving venous thrombo-embolic event (deep vein thrombosis, pulmonary embolism) * Recent or evolving arterial thromboembolic stroke (eg angina, myocardial infarction) * Acute liver disease or history of liver disease, until hepatic tests are normalized * Severe renal insufficiency * Severe, uncontrolled heart failure * Evolutionary gastroduodenal ulcer * History of asthma caused by the administration of salicylates or substances of similar activity, especially nonsteroidal anti-inflammatory drugs * GnRH Agonist Decapeptyl administered within 6 months prior to transfer * To be deprived of liberty or under guardianship * Pregnancy and breast feeding.
๐Ÿ’Š

What it tests

  • GnRH agonist
๐Ÿ“

Where

1 site
Hopital Foch
Suresnes, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy